Monthly Prescribing Reference7d
FDA: Anaphylaxis Risk Prompts Boxed Warning for MS Drug
Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.
Medscape10d
FDA Adds Anaphylaxis Risk Warning to Multiple Sclerosis Drug Glatiramer Acetate
From 1996-2024, 82 cases of anaphylaxis associated with glatiramer acetate were reported to the FDA Adverse Event Reporting ...
MedPage Today10d
FDA Warns About Anaphylaxis Risk With MS Drug
Opens in a new tab or window The FDA added a boxed warning about rare cases of anaphylaxis associated with the multiple sclerosis (MS) drug glatiramer ... within 1 hour of injection and include ...
The Pharma Letter10d
FDA warns of rare but serious allergic reaction with glatiramer
For most patients who experienced anaphylaxis with glatiramer acetate use, the symptoms appeared within one hour of injection. All the news that moves the needle in pharma and biotech Exclusive ...